Waldenstrom’s Macroglobulinaemia Recurrent

Waldenstrom’s macroglobulinaemia is a rare blood cancer that cannot be completely cured, which means that after successful treatment, the disease will eventually return. Understanding what happens when the cancer comes back and knowing your treatment options can help you manage this condition effectively.

Table of contents

• What is Waldenstrom’s Macroglobulinaemia?
• Understanding Remission and Recurrence
• When Treatment Is Needed for Recurrent Disease
• Treatment Options for Relapsed Disease
• Choosing the Right Treatment
• Clinical Trials and Research
• Living with Recurrent Waldenstrom’s Macroglobulinaemia

What is Waldenstrom’s Macroglobulinaemia?

Waldenstrom’s macroglobulinaemia, also called lymphoplasmacytic lymphoma, is a rare type of blood cancer that starts in white blood cells^[1]. In this condition, some white blood cells undergo changes that turn them into cancer cells. These cancer cells build up in the bone marrow (the spongy material inside bones where blood cells are made) and can also accumulate in other parts of the body, such as the lymph nodes and spleen^[1].

The cancer cells produce large amounts of a protein called immunoglobulin M (IgM). When too much of this protein builds up in the blood, it can thicken the blood and reduce blood flow throughout the body, causing various problems^[2]. The disease usually begins in a person’s sixties and is a slow-growing cancer^[2].

Understanding Remission and Recurrence

Waldenstrom’s macroglobulinaemia cannot be completely cured. This means there is no treatment that will kill every cancer cell in your body^[3]. The goal of treatment is to reduce the number of cancer cells, eliminate symptoms, and help you feel better.

When treatment finishes, most people go into what is called remission. During remission, blood tests show no abnormal IgM protein or reduced amounts of it, and symptoms are reduced or have gone away^[3][13]. This period of remission can last for months, years, or even decades because Waldenstrom’s macroglobulinaemia is a slow-growing cancer, and it takes time for the cells to rebuild to levels that cause symptoms^[3].

All patients with Waldenstrom’s macroglobulinaemia will ultimately experience a relapse, meaning the disease will come back^[6][11]. The disease belongs to a group of cancers characterized by a slowly progressing clinical course and recurrent relapses^[11].

When Treatment Is Needed for Recurrent Disease

Not everyone with recurrent Waldenstrom’s macroglobulinaemia needs treatment right away. Just as with the initial diagnosis, a watch-and-wait approach may be appropriate if you have no symptoms^[6][11].

When the disease relapses, your doctor should perform a thorough diagnostic workup^[6][11]. Treatment should only be started if you have specific symptoms or conditions that affect your daily life, such as:

• Symptoms related to the lymphoma, including fever, night sweats, or weight loss
• IgM values that put you at risk of developing hyperviscosity (thickening of the blood), typically when serum IgM is greater than 60 grams per liter
• Low blood cell counts that affect your health
• Lymph nodes or organs that are enlarged and causing symptoms^[6][11]

Treatment Options for Relapsed Disease

There are several treatment approaches available for patients with relapsed Waldenstrom’s macroglobulinaemia^[6][11]. The main types of treatments include:

Rituximab-based regimens: Rituximab is a type of antibody therapy that can be combined with chemotherapy drugs. Common combinations include rituximab with bendamustine, cyclophosphamide, or other chemotherapy agents^[6][11].

Bortezomib-containing regimens: Bortezomib is a proteasome inhibitor, a type of drug that interferes with the breakdown of proteins in cancer cells. It can be used alone or combined with other medications^[6][11].

Ibrutinib and other BTK inhibitors: Ibrutinib is a pill taken by mouth that blocks a specific protein called Bruton’s tyrosine kinase (BTK), which helps cancer cells survive. It is particularly effective for patients who relapse within 12 months after previous treatment^[6][11]. Other BTK inhibitors, such as zanubrutinib and acalabrutinib, are also available^[12][15].

Choosing the Right Treatment

The choice of treatment for relapsed Waldenstrom’s macroglobulinaemia depends on many factors^[6][11]:

How long the remission lasted: The duration of response after your last treatment is critical for selecting the appropriate treatment. If you relapsed within 12 months from your previous therapy, single-agent ibrutinib is often the treatment of choice^[6][11].

Your overall fitness and health: Your doctor will consider your age, other health conditions you may have, and how well you can tolerate treatment^[6][11].

Previous treatments: What treatments you received before and how well they worked will influence what your doctor recommends next^[6][11].

Side effects: Different treatments have different side effects. For example, neuropathy (nerve damage causing numbness and weakness) is more common with bortezomib, while blood cell problems and heart-related side effects are more common with chemotherapy and ibrutinib-based treatments, respectively^[6][11].

Treatment should be tailored to your individual situation. There is no single standard approach for all patients with relapsed disease^[6][11].

Clinical Trials and Research

Whenever possible, patients with relapsed Waldenstrom’s macroglobulinaemia should consider participating in clinical trials^[6][11]. Clinical trials test new treatments and strategies that may be more effective than current options. These studies are essential for advancing our understanding and treatment of this rare disease.

The future goal of research is to develop chemotherapy-free approaches that work regardless of your specific genetic profile and can be given for a limited time rather than indefinitely^[6][11].

Living with Recurrent Waldenstrom’s Macroglobulinaemia

Living with a cancer that comes back can be emotionally challenging. It’s important to remember that many people with recurrent Waldenstrom’s macroglobulinaemia have long periods of good health and quality of life between treatments.

Regular follow-up with your healthcare team is essential. Your doctor will monitor your blood tests and symptoms to determine when treatment is needed^[8][22]. Between treatments, maintaining a healthy lifestyle, including good nutrition and appropriate exercise, can help you feel better and maintain your strength.

Support from family, friends, and patient support groups can make a significant difference in coping with recurrent disease. Many organizations offer resources, information, and connections with other patients who understand what you’re going through.

Although Waldenstrom’s macroglobulinaemia is incurable, it is treatable, and many patients experience long-term responses to therapy^[12]. With advances in treatment options and ongoing research, there is reason for hope in managing this condition effectively.